EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Simultaneous Development and Validation of an HPLC Method for the Determination of Furosemide and Its Degraded Compound in Pediatric Extemporaneous Furosemide Oral Solution

Katsanee Srejomthong iD, Thanawat Pattananandecha iD, Sutasinee Apichai, Suporn Charumanee, Busaban Sirithunyalug iD, Fumihiko Ogata iD, Naohito Kawasaki iD, Chalermpong Saenjum iD

Molecules · 2025

DOI: 10.3390/molecules30194031 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Molecules, 2025. Verfasst von Katsanee Srejomthong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Furosemide. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chiang Mai University, Faculty of Pharmacy, Chiang Mai University, Research Center for Innovation in Analytical Science and Technology for Biodiversity-Based Economic and Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Furosemide (FUR) is a loop diuretic widely used in pediatric care. However, no standardized oral liquid formulation exists due to degradation concerns, particularly the formation of furosemide-related compound B (FUR-B). This study aimed to develop and validate the HPLC method for the simultaneous quantification of FUR, FUR-B, methylparaben (MP), and propylparaben (PP) in pediatric extemporaneous oral solutions. Chromatographic separation was achieved using a Symmetry® C18 column (4.6 × 250 mm, 5 µm) with a mobile phase of 0.1% acetic acid in water and acetonitrile (60:40, v/v) at 1.0 mL/min of flow with injection volume at 10 µL. Detection at 272 nm provided optimal sensitivity, especially for low concentrations of FUR-B. Forced degradation confirmed baseline separation of FUR from its degradation products. The condition showed high linearity (R2 > 0.995), accuracy (recoveries 98.2–101.0%), and precision (RSD ≤ 2%). Robustness and ruggedness tests under varied conditions, analysts, and intra-day yielded consistent performance. Application to extemporaneous formulations showed that refrigeration (2–8 °C) retained initial composition, while elevated temperatures (30 °C and 40 °C) promoted FUR degradation, with FUR-B increasing to 6.84% after 90 days and greater MP and PP degradation. This validated method offers a reliable analytical tool for monitoring chemical changes and supporting quality control of pediatric FUR extemporaneous formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FurosemideChromatography, High Pressure LiquidAdministration, OralHumansDrug StabilityReproducibility of ResultsPharmaceutical SolutionsChildParabens

Stichwörter der Autor:innen

HPLCextemporaneous formulationfurosemidefurosemide related compound Bmethyl parabenpropyl paraben

Substanzen

FurosemidePharmaceutical SolutionsParabensmethylparaben

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Research Center for Innovation in Analytical Science and Technology for Biodiversity-Based Economic and Society (I-ANALY-S-T_B.BES-CMU), Multidisciplinary Research Institute (MDRI), Chiang Mai University, Chiang Mai 502…
  • Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka 577-8502, Osaka, Japan.
  • Antiaging Center, Kindai University, 3-4-1 Kowakae, Higashi-Osaka 577-8502, Osaka, Japan.

ORCID-Profile: Katsanee Srejomthong, Thanawat Pattananandecha, Busaban Sirithunyalug, Fumihiko Ogata, Naohito Kawasaki, Chalermpong Saenjum

Förderung

  • Chiang Mai University
  • Faculty of Pharmacy, Chiang Mai University
  • Research Center for Innovation in Analytical Science and Technology for Biodiversity-Based Economic and Society
  • Multidisciplinary Research Institute (MDRI), Chiang Mai University, Chiang Mai, Thailand

Zitieren

APA

Srejomthong, K., Pattananandecha, T., Apichai, S., Charumanee, S., Sirithunyalug, B., Ogata, F., Kawasaki, N., & Saenjum, C. (2025). Simultaneous Development and Validation of an HPLC Method for the Determination of Furosemide and Its Degraded Compound in Pediatric Extemporaneous Furosemide Oral Solution. Molecules. https://doi.org/10.3390/molecules30194031

Vancouver

Srejomthong K, Pattananandecha T, Apichai S, Charumanee S, Sirithunyalug B, Ogata F, et al. Simultaneous Development and Validation of an HPLC Method for the Determination of Furosemide and Its Degraded Compound in Pediatric Extemporaneous Furosemide Oral Solution. Molecules. 2025. doi:10.3390/molecules30194031

BibTeX
@article{Srejomthong2025,
  author = {Srejomthong, Katsanee and Pattananandecha, Thanawat and Apichai, Sutasinee and Charumanee, Suporn and Sirithunyalug, Busaban and Ogata, Fumihiko and Kawasaki, Naohito and Saenjum, Chalermpong},
  title = {Simultaneous Development and Validation of an HPLC Method for the Determination of Furosemide and Its Degraded Compound in Pediatric Extemporaneous Furosemide Oral Solution},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30194031}
}
Kostenlos starten →